您的购物车当前为空
别名 GNE0723
GNE-0723是一种选择性的NMDAR的阳性变构调节剂,对GluN2A的EC50=21nM,而GluN2C和GluN2D的EC50=6.2~7.4μM,具有可透过血脑屏障(BBB)的优点,可用于改善Dravet综合征(DS)和阿尔茨海默病(AD)。

GNE-0723是一种选择性的NMDAR的阳性变构调节剂,对GluN2A的EC50=21nM,而GluN2C和GluN2D的EC50=6.2~7.4μM,具有可透过血脑屏障(BBB)的优点,可用于改善Dravet综合征(DS)和阿尔茨海默病(AD)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 3,230 | In stock | |
| 5 mg | ¥ 7,490 | In stock | |
| 10 mg | ¥ 9,870 | In stock | |
| 25 mg | ¥ 15,000 | In stock | |
| 50 mg | ¥ 19,800 | In stock |
GNE-0723 相关产品
| 产品描述 | GNE-0723 is a selective positive allosteric modulator of the NMDA receptor, with an EC50 of 21 nM for GluN2A. It can cross the blood-brain barrier (BBB) and improve outcomes in Dravet syndrome (DS) and Alzheimer's disease (AD). |
| 靶点活性 | GluN2C:7.4 μM(EC50), GluN2D:6.2 μM(EC50), GluN2A:21 nM (EC50) |
| 体外活性 | GNE-0723 是一种脑渗透性 NMDAR 正变构调节剂,对 GluN2A/2C/2D 的 EC50 为 21 nM/7.4μM /6.2 μM。[1] |
| 别名 | GNE0723 |
| 分子量 | 467.78 |
| 分子式 | C16H8ClF6N5OS |
| CAS No. | 1883518-31-7 |
| Smiles | C(F)(F)(F)C1=C(N2C(S1)=NC(CN3N=C(C(F)(F)F)C=C3Cl)=CC2=O)[C@H]4[C@H](C#N)C4 |
| 密度 | 1.84 g/cm3 (Predicted) |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 160 mg/mL (342.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容